 MERIAN GLOBAL INVESTORS UK Ltd purchased a new stake in shares of Meridian Bioscience, Inc. NASDAQ:VIVO in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 18,558 shares of the companys stock, valued at approximately 432,000. A number of other hedge funds have also made ... 